BPC-157 reduced TNF-alpha and IL-6 levels in colitis models while preserving mucosal barrier integrity
Ocular drug delivery formulation comprising cellulosic polymer, anionic polysaccharide, nanoparticles comprising amphiphilic block copolymer, and cannabinoid patent WO2018205022
GLP-1s Show Promise for Mental Health Beyond weight loss, emerging research suggests GLP-1 receptor agonists might have direct mental health benefits: Reduced binge-eating and food cravings in patients with BED and obesity Lower rates of substance use in preliminary studies (reduced alcohol and nicotine cravings) Improved mood and quality-of-life scores independent of weight loss No increase in depression or suicidality (the FDA and EMA both reviewed this and found no causal link) In fact, large trials like the STEP studies showed slightly lower rates of depressive symptoms in GLP-1-treated groups compared to placebo
Moreover, using glutathione may help reduce spots and hyperpigmentation levels (3)
Advertisement Study highlights strong predictive value of circulating tumor DNA testing Researchers with Cleveland Clinic in Florida highlight need for a national registry for gastrointestinal stromal tumors Multidisciplinary LARS Center addresses life-altering consequence of rectal cancer surgery Early recognition and intervention recommended in cubital tunnel syndrome Manpreet (Meena) Bedi, MD, named Division Chair of Radiation Oncology AR-assisted navigation is closing the gap between surgical planning and implant placement Evidence shows early evaluation improves survival and quality of life yet many eligible patients are referred too late 2026 ADA Standards of Care promote holistic, multisystem management
